We have located links that may give you full text access.
Ilio-femoral and femoro-femoral crossover grafting. Analysis of an 11-year experience.
Experience with 131 crossover arterial bypass grafts for lower limb revascularization has been reviewed. Ninety-nine grafts were placed as a primary procedure for unilateral iliac artery occlusive (97) or aneurysmal (2) disease. In contrast 32 grafts were placed as a secondary procedure following the failure of a previous unilateral or bilateral conventional aorto-iliac reconstruction. Fifteen patients were not suitable for a crossover procedure without the addition of a concomitant donor limb inflow reconstruction. The one month operative mortality rate was 6.1%. The five-year cumulative patency rate was 71.4% +/- 6.0 in primary procedures and 38.1% +/- 11.3 in secondary procedures (p less than 0.05). No difference in the success rate was shown when the vein graft patency curve was compared with the synthetic graft patency curve. However, the use of a small caliber vein (6 mm or less) resulted in the lowest patency rate. No other factors affecting patency were found. This report tends to support the fact that ilio-femoral or femoro-femoral crossover bypass is a safe and effective procedure for managing unilateral iliac artery occlusive disease. With proper selection of patients, a wider use of the method is justified.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app